IFP Advisors Inc Has $799,000 Stock Position in SPDR S&P Biotech ETF $XBI

IFP Advisors Inc lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 222.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,553 shares of the exchange traded fund’s stock after buying an additional 4,522 shares during the quarter. IFP Advisors Inc’s holdings in SPDR S&P Biotech ETF were worth $799,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Dynamic Wealth Strategies LLC lifted its stake in shares of SPDR S&P Biotech ETF by 3.8% in the fourth quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock worth $268,000 after buying an additional 80 shares during the last quarter. Capital Investment Advisory Services LLC lifted its stake in shares of SPDR S&P Biotech ETF by 4.0% in the fourth quarter. Capital Investment Advisory Services LLC now owns 2,123 shares of the exchange traded fund’s stock worth $259,000 after buying an additional 81 shares during the last quarter. Compass Ion Advisors LLC lifted its stake in shares of SPDR S&P Biotech ETF by 2.6% in the fourth quarter. Compass Ion Advisors LLC now owns 3,886 shares of the exchange traded fund’s stock worth $474,000 after buying an additional 97 shares during the last quarter. Moors & Cabot Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 3.8% in the third quarter. Moors & Cabot Inc. now owns 2,717 shares of the exchange traded fund’s stock worth $272,000 after buying an additional 100 shares during the last quarter. Finally, Sequoia Financial Advisors LLC lifted its stake in shares of SPDR S&P Biotech ETF by 3.1% in the third quarter. Sequoia Financial Advisors LLC now owns 3,393 shares of the exchange traded fund’s stock worth $340,000 after buying an additional 101 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $131.66 on Monday. The firm has a fifty day simple moving average of $129.82 and a 200-day simple moving average of $125.16. SPDR S&P Biotech ETF has a 1-year low of $78.00 and a 1-year high of $139.19. The stock has a market capitalization of $8.40 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.